NCT01012934View on ClinicalTrials.gov

Fasting Study of Alendronate Sodium Tablets (70 mg) and Fosamax Tablets (70 mg)

PHASE1CompletedINTERVENTIONAL
Enrollment

110

Participants

Timeline

Start Date

July 31, 2002

Primary Completion Date

August 31, 2002

Study Completion Date

August 31, 2002

Conditions
Healthy
Interventions
DRUG

Alendronate Sodium Tablets, 70 mg

1 x 70 mg, single-dose fasting

DRUG

Fosamax Tablets, 70 mg

1 x 70 mg, single-dose fasting

Trial Locations (1)

58104

PRACS Insitute Ltd., Fargo

Sponsors
All Listed Sponsors
lead

Mylan Pharmaceuticals Inc

INDUSTRY